nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—Gingival hypertrophy—Everolimus—kidney cancer	0.078	0.165	CcSEcCtD
Ethotoin—Non-Hodgkin's lymphoma—Everolimus—kidney cancer	0.0186	0.0394	CcSEcCtD
Ethotoin—Lymphoma—Everolimus—kidney cancer	0.0186	0.0394	CcSEcCtD
Ethotoin—Non-Hodgkin's lymphoma—Gemcitabine—kidney cancer	0.0125	0.0264	CcSEcCtD
Ethotoin—Lymphoma—Gemcitabine—kidney cancer	0.0125	0.0264	CcSEcCtD
Ethotoin—Nystagmus—Vinblastine—kidney cancer	0.00913	0.0193	CcSEcCtD
Ethotoin—Numbness—Vinblastine—kidney cancer	0.00787	0.0167	CcSEcCtD
Ethotoin—Sensory loss—Vinblastine—kidney cancer	0.00753	0.0159	CcSEcCtD
Ethotoin—Systemic lupus erythematosus—Paclitaxel—kidney cancer	0.00659	0.0139	CcSEcCtD
Ethotoin—Nystagmus—Vincristine—kidney cancer	0.00643	0.0136	CcSEcCtD
Ethotoin—Numbness—Vincristine—kidney cancer	0.00554	0.0117	CcSEcCtD
Ethotoin—Lymphadenopathy—Everolimus—kidney cancer	0.00553	0.0117	CcSEcCtD
Ethotoin—Sensory loss—Vincristine—kidney cancer	0.0053	0.0112	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Temsirolimus—kidney cancer	0.00485	0.0103	CcSEcCtD
Ethotoin—Sensory loss—Paclitaxel—kidney cancer	0.00421	0.00891	CcSEcCtD
Ethotoin—Erythema multiforme—Temsirolimus—kidney cancer	0.00415	0.00878	CcSEcCtD
Ethotoin—Hypoaesthesia—Pazopanib—kidney cancer	0.00411	0.00871	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Erlotinib—kidney cancer	0.00348	0.00736	CcSEcCtD
Ethotoin—Hypoaesthesia—Vinblastine—kidney cancer	0.00326	0.0069	CcSEcCtD
Ethotoin—Chest pain—Temsirolimus—kidney cancer	0.00325	0.00689	CcSEcCtD
Ethotoin—Hypoaesthesia—Everolimus—kidney cancer	0.00325	0.00688	CcSEcCtD
Ethotoin—Ataxia—Vincristine—kidney cancer	0.00313	0.00664	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Sorafenib—kidney cancer	0.00313	0.00663	CcSEcCtD
Ethotoin—Chest pain—Pazopanib—kidney cancer	0.00306	0.00649	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Sunitinib—kidney cancer	0.00301	0.00638	CcSEcCtD
Ethotoin—Erythema multiforme—Erlotinib—kidney cancer	0.00298	0.00631	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Dactinomycin—kidney cancer	0.00285	0.00604	CcSEcCtD
Ethotoin—Insomnia—Temsirolimus—kidney cancer	0.00282	0.00597	CcSEcCtD
Ethotoin—Hypoaesthesia—Sunitinib—kidney cancer	0.00271	0.00574	CcSEcCtD
Ethotoin—Nystagmus—Doxorubicin—kidney cancer	0.0027	0.00572	CcSEcCtD
Ethotoin—Fatigue—Temsirolimus—kidney cancer	0.00269	0.00569	CcSEcCtD
Ethotoin—Erythema multiforme—Sorafenib—kidney cancer	0.00268	0.00567	CcSEcCtD
Ethotoin—Insomnia—Pazopanib—kidney cancer	0.00266	0.00562	CcSEcCtD
Ethotoin—CYP2C19—urine—kidney cancer	0.00265	0.182	CbGeAlD
Ethotoin—Erythema multiforme—Sunitinib—kidney cancer	0.00258	0.00546	CcSEcCtD
Ethotoin—Fatigue—Pazopanib—kidney cancer	0.00253	0.00536	CcSEcCtD
Ethotoin—Ataxia—Paclitaxel—kidney cancer	0.00249	0.00527	CcSEcCtD
Ethotoin—Body temperature increased—Temsirolimus—kidney cancer	0.00246	0.00522	CcSEcCtD
Ethotoin—Erythema multiforme—Dactinomycin—kidney cancer	0.00244	0.00517	CcSEcCtD
Ethotoin—Chest pain—Everolimus—kidney cancer	0.00242	0.00512	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.00242	0.00512	CcSEcCtD
Ethotoin—Chest pain—Erlotinib—kidney cancer	0.00233	0.00494	CcSEcCtD
Ethotoin—Hypoaesthesia—Vincristine—kidney cancer	0.00229	0.00486	CcSEcCtD
Ethotoin—Asthenia—Temsirolimus—kidney cancer	0.00224	0.00474	CcSEcCtD
Ethotoin—Diplopia—Capecitabine—kidney cancer	0.00217	0.0046	CcSEcCtD
Ethotoin—Diarrhoea—Temsirolimus—kidney cancer	0.00213	0.00452	CcSEcCtD
Ethotoin—Asthenia—Pazopanib—kidney cancer	0.00211	0.00446	CcSEcCtD
Ethotoin—Insomnia—Everolimus—kidney cancer	0.0021	0.00444	CcSEcCtD
Ethotoin—Erythema multiforme—Gemcitabine—kidney cancer	0.00207	0.00438	CcSEcCtD
Ethotoin—Dizziness—Temsirolimus—kidney cancer	0.00206	0.00437	CcSEcCtD
Ethotoin—Ataxia—Capecitabine—kidney cancer	0.00204	0.00433	CcSEcCtD
Ethotoin—Insomnia—Erlotinib—kidney cancer	0.00202	0.00428	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.00202	0.00428	CcSEcCtD
Ethotoin—Chest pain—Sunitinib—kidney cancer	0.00202	0.00428	CcSEcCtD
Ethotoin—Diarrhoea—Pazopanib—kidney cancer	0.00201	0.00425	CcSEcCtD
Ethotoin—Fatigue—Everolimus—kidney cancer	0.002	0.00423	CcSEcCtD
Ethotoin—Vomiting—Temsirolimus—kidney cancer	0.00198	0.0042	CcSEcCtD
Ethotoin—Rash—Temsirolimus—kidney cancer	0.00197	0.00416	CcSEcCtD
Ethotoin—Dermatitis—Temsirolimus—kidney cancer	0.00196	0.00416	CcSEcCtD
Ethotoin—Headache—Temsirolimus—kidney cancer	0.00195	0.00414	CcSEcCtD
Ethotoin—Dizziness—Pazopanib—kidney cancer	0.00194	0.00411	CcSEcCtD
Ethotoin—Fatigue—Erlotinib—kidney cancer	0.00193	0.00408	CcSEcCtD
Ethotoin—Vomiting—Pazopanib—kidney cancer	0.00187	0.00395	CcSEcCtD
Ethotoin—Rash—Pazopanib—kidney cancer	0.00185	0.00392	CcSEcCtD
Ethotoin—Nausea—Temsirolimus—kidney cancer	0.00185	0.00392	CcSEcCtD
Ethotoin—Dermatitis—Pazopanib—kidney cancer	0.00185	0.00392	CcSEcCtD
Ethotoin—Headache—Pazopanib—kidney cancer	0.00184	0.0039	CcSEcCtD
Ethotoin—Body temperature increased—Everolimus—kidney cancer	0.00183	0.00388	CcSEcCtD
Ethotoin—Hypoaesthesia—Paclitaxel—kidney cancer	0.00182	0.00386	CcSEcCtD
Ethotoin—Body temperature increased—Erlotinib—kidney cancer	0.00177	0.00375	CcSEcCtD
Ethotoin—Insomnia—Sunitinib—kidney cancer	0.00175	0.00371	CcSEcCtD
Ethotoin—Nausea—Pazopanib—kidney cancer	0.00174	0.00369	CcSEcCtD
Ethotoin—Fatigue—Sorafenib—kidney cancer	0.00174	0.00367	CcSEcCtD
Ethotoin—Erythema multiforme—Paclitaxel—kidney cancer	0.00173	0.00367	CcSEcCtD
Ethotoin—Asthenia—Vinblastine—kidney cancer	0.00167	0.00354	CcSEcCtD
Ethotoin—Fatigue—Sunitinib—kidney cancer	0.00167	0.00354	CcSEcCtD
Ethotoin—Asthenia—Everolimus—kidney cancer	0.00166	0.00352	CcSEcCtD
Ethotoin—SCN7A—cardiac atrium—kidney cancer	0.00166	0.114	CbGeAlD
Ethotoin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00166	0.00351	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—kidney cancer	0.00164	0.00348	CcSEcCtD
Ethotoin—Chest pain—Gemcitabine—kidney cancer	0.00162	0.00343	CcSEcCtD
Ethotoin—Asthenia—Erlotinib—kidney cancer	0.00161	0.0034	CcSEcCtD
Ethotoin—SCN9A—nephron tubule—kidney cancer	0.0016	0.11	CbGeAlD
Ethotoin—Diarrhoea—Vinblastine—kidney cancer	0.00159	0.00337	CcSEcCtD
Ethotoin—Body temperature increased—Sorafenib—kidney cancer	0.00159	0.00337	CcSEcCtD
Ethotoin—Diarrhoea—Everolimus—kidney cancer	0.00159	0.00336	CcSEcCtD
Ethotoin—Fatigue—Dactinomycin—kidney cancer	0.00158	0.00335	CcSEcCtD
Ethotoin—Dizziness—Vinblastine—kidney cancer	0.00154	0.00326	CcSEcCtD
Ethotoin—Dizziness—Everolimus—kidney cancer	0.00153	0.00325	CcSEcCtD
Ethotoin—Body temperature increased—Sunitinib—kidney cancer	0.00153	0.00324	CcSEcCtD
Ethotoin—Diarrhoea—Erlotinib—kidney cancer	0.00153	0.00324	CcSEcCtD
Ethotoin—Hypoaesthesia—Capecitabine—kidney cancer	0.0015	0.00317	CcSEcCtD
Ethotoin—Insomnia—Vincristine—kidney cancer	0.00148	0.00314	CcSEcCtD
Ethotoin—Vomiting—Vinblastine—kidney cancer	0.00148	0.00313	CcSEcCtD
Ethotoin—Dizziness—Erlotinib—kidney cancer	0.00148	0.00313	CcSEcCtD
Ethotoin—Vomiting—Everolimus—kidney cancer	0.00147	0.00312	CcSEcCtD
Ethotoin—Rash—Everolimus—kidney cancer	0.00146	0.0031	CcSEcCtD
Ethotoin—Dermatitis—Everolimus—kidney cancer	0.00146	0.00309	CcSEcCtD
Ethotoin—Headache—Vinblastine—kidney cancer	0.00146	0.00309	CcSEcCtD
Ethotoin—Headache—Everolimus—kidney cancer	0.00145	0.00308	CcSEcCtD
Ethotoin—Body temperature increased—Dactinomycin—kidney cancer	0.00145	0.00307	CcSEcCtD
Ethotoin—Asthenia—Sorafenib—kidney cancer	0.00144	0.00306	CcSEcCtD
Ethotoin—Vomiting—Erlotinib—kidney cancer	0.00142	0.00301	CcSEcCtD
Ethotoin—Erythema multiforme—Capecitabine—kidney cancer	0.00142	0.00301	CcSEcCtD
Ethotoin—Fatigue—Vincristine—kidney cancer	0.00141	0.00299	CcSEcCtD
Ethotoin—Rash—Erlotinib—kidney cancer	0.00141	0.00299	CcSEcCtD
Ethotoin—Dermatitis—Erlotinib—kidney cancer	0.00141	0.00298	CcSEcCtD
Ethotoin—Insomnia—Gemcitabine—kidney cancer	0.00141	0.00298	CcSEcCtD
Ethotoin—Headache—Erlotinib—kidney cancer	0.0014	0.00297	CcSEcCtD
Ethotoin—Diplopia—Doxorubicin—kidney cancer	0.0014	0.00297	CcSEcCtD
Ethotoin—Asthenia—Sunitinib—kidney cancer	0.00139	0.00294	CcSEcCtD
Ethotoin—Nausea—Vinblastine—kidney cancer	0.00138	0.00293	CcSEcCtD
Ethotoin—Nausea—Everolimus—kidney cancer	0.00138	0.00292	CcSEcCtD
Ethotoin—Diarrhoea—Sorafenib—kidney cancer	0.00138	0.00292	CcSEcCtD
Ethotoin—Chest pain—Paclitaxel—kidney cancer	0.00136	0.00287	CcSEcCtD
Ethotoin—Fatigue—Gemcitabine—kidney cancer	0.00134	0.00284	CcSEcCtD
Ethotoin—Dizziness—Sorafenib—kidney cancer	0.00133	0.00282	CcSEcCtD
Ethotoin—Nausea—Erlotinib—kidney cancer	0.00133	0.00281	CcSEcCtD
Ethotoin—Diarrhoea—Sunitinib—kidney cancer	0.00133	0.00281	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—kidney cancer	0.00132	0.00279	CcSEcCtD
Ethotoin—Asthenia—Dactinomycin—kidney cancer	0.00132	0.00279	CcSEcCtD
Ethotoin—SCN4A—renal system—kidney cancer	0.0013	0.0889	CbGeAlD
Ethotoin—Body temperature increased—Vincristine—kidney cancer	0.0013	0.00274	CcSEcCtD
Ethotoin—Dizziness—Sunitinib—kidney cancer	0.00128	0.00271	CcSEcCtD
Ethotoin—Vomiting—Sorafenib—kidney cancer	0.00128	0.00271	CcSEcCtD
Ethotoin—Rash—Sorafenib—kidney cancer	0.00127	0.00269	CcSEcCtD
Ethotoin—Dermatitis—Sorafenib—kidney cancer	0.00127	0.00268	CcSEcCtD
Ethotoin—Headache—Sorafenib—kidney cancer	0.00126	0.00267	CcSEcCtD
Ethotoin—Diarrhoea—Dactinomycin—kidney cancer	0.00125	0.00266	CcSEcCtD
Ethotoin—SCN4A—kidney—kidney cancer	0.00125	0.0859	CbGeAlD
Ethotoin—Vomiting—Sunitinib—kidney cancer	0.00123	0.00261	CcSEcCtD
Ethotoin—Body temperature increased—Gemcitabine—kidney cancer	0.00123	0.0026	CcSEcCtD
Ethotoin—Rash—Sunitinib—kidney cancer	0.00122	0.00259	CcSEcCtD
Ethotoin—Dermatitis—Sunitinib—kidney cancer	0.00122	0.00258	CcSEcCtD
Ethotoin—SCN10A—nephron tubule—kidney cancer	0.00122	0.0834	CbGeAlD
Ethotoin—Headache—Sunitinib—kidney cancer	0.00121	0.00257	CcSEcCtD
Ethotoin—Nausea—Sorafenib—kidney cancer	0.0012	0.00253	CcSEcCtD
Ethotoin—Insomnia—Paclitaxel—kidney cancer	0.00118	0.00249	CcSEcCtD
Ethotoin—Asthenia—Vincristine—kidney cancer	0.00118	0.00249	CcSEcCtD
Ethotoin—Vomiting—Dactinomycin—kidney cancer	0.00117	0.00247	CcSEcCtD
Ethotoin—Rash—Dactinomycin—kidney cancer	0.00116	0.00245	CcSEcCtD
Ethotoin—Nausea—Sunitinib—kidney cancer	0.00115	0.00244	CcSEcCtD
Ethotoin—Fatigue—Paclitaxel—kidney cancer	0.00112	0.00238	CcSEcCtD
Ethotoin—Diarrhoea—Vincristine—kidney cancer	0.00112	0.00237	CcSEcCtD
Ethotoin—Asthenia—Gemcitabine—kidney cancer	0.00112	0.00236	CcSEcCtD
Ethotoin—Chest pain—Capecitabine—kidney cancer	0.00111	0.00236	CcSEcCtD
Ethotoin—Nausea—Dactinomycin—kidney cancer	0.00109	0.00231	CcSEcCtD
Ethotoin—Dizziness—Vincristine—kidney cancer	0.00108	0.00229	CcSEcCtD
Ethotoin—SCN2A—cortex of kidney—kidney cancer	0.00108	0.0741	CbGeAlD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00107	0.00227	CcSEcCtD
Ethotoin—Diarrhoea—Gemcitabine—kidney cancer	0.00106	0.00225	CcSEcCtD
Ethotoin—Vomiting—Vincristine—kidney cancer	0.00104	0.00221	CcSEcCtD
Ethotoin—Rash—Vincristine—kidney cancer	0.00103	0.00219	CcSEcCtD
Ethotoin—Dermatitis—Vincristine—kidney cancer	0.00103	0.00219	CcSEcCtD
Ethotoin—Body temperature increased—Paclitaxel—kidney cancer	0.00103	0.00218	CcSEcCtD
Ethotoin—Headache—Vincristine—kidney cancer	0.00103	0.00217	CcSEcCtD
Ethotoin—SCN3A—renal system—kidney cancer	0.00101	0.0691	CbGeAlD
Ethotoin—Vomiting—Gemcitabine—kidney cancer	0.000988	0.00209	CcSEcCtD
Ethotoin—Rash—Gemcitabine—kidney cancer	0.00098	0.00207	CcSEcCtD
Ethotoin—Dermatitis—Gemcitabine—kidney cancer	0.000979	0.00207	CcSEcCtD
Ethotoin—SCN3A—kidney—kidney cancer	0.000975	0.0668	CbGeAlD
Ethotoin—Headache—Gemcitabine—kidney cancer	0.000974	0.00206	CcSEcCtD
Ethotoin—Nausea—Vincristine—kidney cancer	0.000973	0.00206	CcSEcCtD
Ethotoin—Insomnia—Capecitabine—kidney cancer	0.000966	0.00205	CcSEcCtD
Ethotoin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000964	0.00204	CcSEcCtD
Ethotoin—SCN3A—cortex of kidney—kidney cancer	0.00095	0.0651	CbGeAlD
Ethotoin—Asthenia—Paclitaxel—kidney cancer	0.000934	0.00198	CcSEcCtD
Ethotoin—Nausea—Gemcitabine—kidney cancer	0.000923	0.00195	CcSEcCtD
Ethotoin—Fatigue—Capecitabine—kidney cancer	0.000921	0.00195	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—kidney cancer	0.000916	0.00194	CcSEcCtD
Ethotoin—SCN5A—cardiac atrium—kidney cancer	0.000901	0.0617	CbGeAlD
Ethotoin—Diarrhoea—Paclitaxel—kidney cancer	0.00089	0.00189	CcSEcCtD
Ethotoin—Dizziness—Paclitaxel—kidney cancer	0.000861	0.00182	CcSEcCtD
Ethotoin—Body temperature increased—Capecitabine—kidney cancer	0.000844	0.00179	CcSEcCtD
Ethotoin—Vomiting—Paclitaxel—kidney cancer	0.000827	0.00175	CcSEcCtD
Ethotoin—Rash—Paclitaxel—kidney cancer	0.00082	0.00174	CcSEcCtD
Ethotoin—Dermatitis—Paclitaxel—kidney cancer	0.00082	0.00174	CcSEcCtD
Ethotoin—Headache—Paclitaxel—kidney cancer	0.000815	0.00173	CcSEcCtD
Ethotoin—Nausea—Paclitaxel—kidney cancer	0.000773	0.00164	CcSEcCtD
Ethotoin—Asthenia—Capecitabine—kidney cancer	0.000766	0.00162	CcSEcCtD
Ethotoin—Diarrhoea—Capecitabine—kidney cancer	0.000731	0.00155	CcSEcCtD
Ethotoin—Chest pain—Doxorubicin—kidney cancer	0.000718	0.00152	CcSEcCtD
Ethotoin—Dizziness—Capecitabine—kidney cancer	0.000706	0.0015	CcSEcCtD
Ethotoin—Vomiting—Capecitabine—kidney cancer	0.000679	0.00144	CcSEcCtD
Ethotoin—Rash—Capecitabine—kidney cancer	0.000673	0.00143	CcSEcCtD
Ethotoin—Dermatitis—Capecitabine—kidney cancer	0.000673	0.00142	CcSEcCtD
Ethotoin—Headache—Capecitabine—kidney cancer	0.000669	0.00142	CcSEcCtD
Ethotoin—Nausea—Capecitabine—kidney cancer	0.000634	0.00134	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—kidney cancer	0.000623	0.00132	CcSEcCtD
Ethotoin—Fatigue—Doxorubicin—kidney cancer	0.000593	0.00126	CcSEcCtD
Ethotoin—Body temperature increased—Doxorubicin—kidney cancer	0.000544	0.00115	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—kidney cancer	0.000494	0.00105	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—kidney cancer	0.000471	0.000997	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—kidney cancer	0.000455	0.000964	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—kidney cancer	0.000438	0.000927	CcSEcCtD
Ethotoin—Rash—Doxorubicin—kidney cancer	0.000434	0.000919	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—kidney cancer	0.000434	0.000918	CcSEcCtD
Ethotoin—Headache—Doxorubicin—kidney cancer	0.000431	0.000913	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—kidney cancer	0.000409	0.000866	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—PAK1—kidney cancer	0.000401	0.000782	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000387	0.000754	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—PAK1—kidney cancer	0.000384	0.000748	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—RAF1—kidney cancer	0.000384	0.000747	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—ERBB2—kidney cancer	0.000379	0.000739	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KDR—kidney cancer	0.000379	0.000738	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MET—kidney cancer	0.00037	0.000722	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—PAK1—kidney cancer	0.000369	0.000718	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—PAK1—kidney cancer	0.000369	0.000718	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—PAK1—kidney cancer	0.000355	0.000693	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000355	0.000693	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—PAK1—kidney cancer	0.00035	0.000682	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KDR—kidney cancer	0.00035	0.000682	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MET—kidney cancer	0.000342	0.000667	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—RAF1—kidney cancer	0.000342	0.000666	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—ERBB2—kidney cancer	0.000338	0.000659	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KDR—kidney cancer	0.000337	0.000658	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KDR—kidney cancer	0.000335	0.000652	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000334	0.000652	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MET—kidney cancer	0.00033	0.000643	CbGpPWpGaD
Ethotoin—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00033	0.000643	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MET—kidney cancer	0.000327	0.000638	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KDR—kidney cancer	0.000321	0.000626	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KDR—kidney cancer	0.000321	0.000626	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MET—kidney cancer	0.000315	0.000613	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MET—kidney cancer	0.000315	0.000613	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—RAF1—kidney cancer	0.000313	0.000609	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KDR—kidney cancer	0.00031	0.000604	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KDR—kidney cancer	0.00031	0.000604	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—ERBB2—kidney cancer	0.000309	0.000603	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KDR—kidney cancer	0.000309	0.000601	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MET—kidney cancer	0.000303	0.000591	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MET—kidney cancer	0.000303	0.000591	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MET—kidney cancer	0.000302	0.000589	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CTNNA1—kidney cancer	0.000301	0.000587	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—MAPK3—kidney cancer	0.0003	0.000586	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—VEGFA—kidney cancer	0.000292	0.00057	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—PAX6—kidney cancer	0.000288	0.000562	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—MAPK1—kidney cancer	0.000286	0.000557	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—MAPK3—kidney cancer	0.000276	0.000539	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—RAF1—kidney cancer	0.000274	0.000533	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—RELA—kidney cancer	0.000272	0.000531	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000271	0.000528	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—ERBB2—kidney cancer	0.000271	0.000528	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—MAPK1—kidney cancer	0.000263	0.000513	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—VEGFA—kidney cancer	0.00026	0.000508	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—RAF1—kidney cancer	0.000253	0.000493	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—ERBB2—kidney cancer	0.00025	0.000488	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—PAK1—kidney cancer	0.00025	0.000487	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KDR—kidney cancer	0.00025	0.000486	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000249	0.000486	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—KRAS—kidney cancer	0.000248	0.000484	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000247	0.00048	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—MAPK3—kidney cancer	0.000246	0.00048	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000245	0.000477	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MET—kidney cancer	0.000244	0.000476	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—RAF1—kidney cancer	0.000244	0.000475	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—RELA—kidney cancer	0.000243	0.000473	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—RAF1—kidney cancer	0.000242	0.000471	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—ERBB2—kidney cancer	0.000241	0.00047	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—ERBB2—kidney cancer	0.000239	0.000466	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KDR—kidney cancer	0.000239	0.000465	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTT1—kidney cancer	0.000238	0.000465	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—VEGFA—kidney cancer	0.000238	0.000464	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—CTNNB1—kidney cancer	0.000237	0.000462	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—MAPK1—kidney cancer	0.000234	0.000457	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MET—kidney cancer	0.000234	0.000455	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—RAF1—kidney cancer	0.000232	0.000453	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—RAF1—kidney cancer	0.000232	0.000453	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	0.00023	0.000448	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—ERBB2—kidney cancer	0.00023	0.000448	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—ERBB2—kidney cancer	0.00023	0.000448	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KDR—kidney cancer	0.000229	0.000447	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KDR—kidney cancer	0.000229	0.000447	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—MAPK3—kidney cancer	0.000225	0.000439	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MET—kidney cancer	0.000224	0.000437	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MET—kidney cancer	0.000224	0.000437	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—RAF1—kidney cancer	0.000224	0.000437	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—RAF1—kidney cancer	0.000224	0.000437	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—PTGS1—kidney cancer	0.000223	0.000435	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—RAF1—kidney cancer	0.000223	0.000435	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—RELA—kidney cancer	0.000222	0.000433	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—ERBB2—kidney cancer	0.000222	0.000432	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—ERBB2—kidney cancer	0.000222	0.000432	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—KRAS—kidney cancer	0.000221	0.000432	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KDR—kidney cancer	0.000221	0.000431	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KDR—kidney cancer	0.000221	0.000431	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—ERBB2—kidney cancer	0.000221	0.00043	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KDR—kidney cancer	0.000218	0.000425	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MET—kidney cancer	0.000216	0.000422	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MET—kidney cancer	0.000216	0.000422	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000215	0.00042	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—MAPK1—kidney cancer	0.000214	0.000418	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MET—kidney cancer	0.000213	0.000416	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CTNNB1—kidney cancer	0.000211	0.000411	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—VEGFA—kidney cancer	0.000209	0.000406	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—KRAS—kidney cancer	0.000203	0.000395	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000202	0.000394	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MAPK3—kidney cancer	0.000197	0.000384	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000197	0.000384	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CTNNB1—kidney cancer	0.000193	0.000376	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—VEGFA—kidney cancer	0.000193	0.000375	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MAPK1—kidney cancer	0.000188	0.000366	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—VEGFA—kidney cancer	0.000186	0.000362	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—VEGFA—kidney cancer	0.000184	0.000359	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MAPK3—kidney cancer	0.000182	0.000355	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—RAF1—kidney cancer	0.00018	0.000352	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—RELA—kidney cancer	0.00018	0.00035	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ERBB2—kidney cancer	0.000179	0.000348	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KRAS—kidney cancer	0.000177	0.000346	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—VEGFA—kidney cancer	0.000177	0.000345	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—VEGFA—kidney cancer	0.000177	0.000345	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MAPK3—kidney cancer	0.000176	0.000343	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MAPK3—kidney cancer	0.000174	0.00034	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MAPK1—kidney cancer	0.000173	0.000338	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—RAF1—kidney cancer	0.000173	0.000336	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—RELA—kidney cancer	0.000172	0.000335	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ERBB2—kidney cancer	0.000171	0.000333	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—VEGFA—kidney cancer	0.000171	0.000333	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—VEGFA—kidney cancer	0.000171	0.000333	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—VEGFA—kidney cancer	0.00017	0.000331	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MAPK3—kidney cancer	0.000167	0.000326	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MAPK3—kidney cancer	0.000167	0.000326	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MAPK1—kidney cancer	0.000167	0.000326	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MAPK1—kidney cancer	0.000166	0.000323	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—RAF1—kidney cancer	0.000166	0.000323	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—RAF1—kidney cancer	0.000166	0.000323	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTP1—kidney cancer	0.000165	0.000322	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—RELA—kidney cancer	0.000165	0.000322	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—RELA—kidney cancer	0.000165	0.000322	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ERBB2—kidney cancer	0.000164	0.00032	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ERBB2—kidney cancer	0.000164	0.00032	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KRAS—kidney cancer	0.000164	0.000319	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	0.000163	0.000318	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MAPK3—kidney cancer	0.000162	0.000315	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MAPK3—kidney cancer	0.000162	0.000315	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MAPK3—kidney cancer	0.000161	0.000313	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—RAF1—kidney cancer	0.00016	0.000312	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—RAF1—kidney cancer	0.00016	0.000312	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MAPK1—kidney cancer	0.000159	0.000311	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MAPK1—kidney cancer	0.000159	0.000311	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—RELA—kidney cancer	0.000159	0.00031	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—RELA—kidney cancer	0.000159	0.00031	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ERBB2—kidney cancer	0.000158	0.000308	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ERBB2—kidney cancer	0.000158	0.000308	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KRAS—kidney cancer	0.000158	0.000308	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—RAF1—kidney cancer	0.000158	0.000307	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KRAS—kidney cancer	0.000157	0.000305	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CTNNB1—kidney cancer	0.000156	0.000304	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ERBB2—kidney cancer	0.000156	0.000304	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KDR—kidney cancer	0.000155	0.000303	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MAPK1—kidney cancer	0.000154	0.000299	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MAPK1—kidney cancer	0.000154	0.000299	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MAPK1—kidney cancer	0.000153	0.000298	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MET—kidney cancer	0.000152	0.000297	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTM1—kidney cancer	0.000152	0.000296	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—kidney cancer	0.000151	0.000293	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—kidney cancer	0.000151	0.000293	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	0.00015	0.000292	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CTNNB1—kidney cancer	0.000149	0.000291	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—kidney cancer	0.000145	0.000283	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—kidney cancer	0.000145	0.000283	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—kidney cancer	0.000145	0.000282	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	0.000144	0.000281	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CTNNB1—kidney cancer	0.000144	0.00028	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CTNNB1—kidney cancer	0.000144	0.00028	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	0.000142	0.000277	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CTNNB1—kidney cancer	0.000138	0.00027	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CTNNB1—kidney cancer	0.000138	0.00027	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—VEGFA—kidney cancer	0.000137	0.000268	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—VEGFA—kidney cancer	0.000132	0.000256	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MAPK3—kidney cancer	0.00013	0.000253	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ACY1—kidney cancer	0.000127	0.000247	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—VEGFA—kidney cancer	0.000126	0.000246	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—VEGFA—kidney cancer	0.000126	0.000246	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MAPK3—kidney cancer	0.000124	0.000242	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MAPK1—kidney cancer	0.000124	0.000241	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—VEGFA—kidney cancer	0.000122	0.000237	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—VEGFA—kidney cancer	0.000122	0.000237	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—VEGFA—kidney cancer	0.00012	0.000234	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MAPK3—kidney cancer	0.00012	0.000233	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MAPK3—kidney cancer	0.00012	0.000233	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MAPK1—kidney cancer	0.000118	0.000231	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—kidney cancer	0.000117	0.000228	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MAPK3—kidney cancer	0.000115	0.000225	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MAPK3—kidney cancer	0.000115	0.000225	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MAPK1—kidney cancer	0.000114	0.000222	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MAPK1—kidney cancer	0.000114	0.000222	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MAPK3—kidney cancer	0.000114	0.000221	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—RAF1—kidney cancer	0.000112	0.000219	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—RELA—kidney cancer	0.000112	0.000218	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—kidney cancer	0.000112	0.000218	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—kidney cancer	0.000111	0.000217	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MAPK1—kidney cancer	0.00011	0.000214	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MAPK1—kidney cancer	0.00011	0.000214	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MAPK1—kidney cancer	0.000108	0.000211	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000108	0.00021	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PDHB—kidney cancer	0.000108	0.00021	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—kidney cancer	0.000107	0.000209	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—kidney cancer	0.000107	0.000209	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—POMC—kidney cancer	0.000107	0.000209	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—kidney cancer	0.000104	0.000202	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—kidney cancer	0.000104	0.000202	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—kidney cancer	0.000102	0.000199	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CCBL1—kidney cancer	0.000101	0.000197	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CTNNB1—kidney cancer	9.73e-05	0.00019	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	9.16e-05	0.000178	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPAT—kidney cancer	8.78e-05	0.000171	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GLIPR1—kidney cancer	8.78e-05	0.000171	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	8.67e-05	0.000169	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.58e-05	0.000167	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—VEGFA—kidney cancer	8.57e-05	0.000167	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—FH—kidney cancer	8.16e-05	0.000159	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—APRT—kidney cancer	8.16e-05	0.000159	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MAPK3—kidney cancer	8.1e-05	0.000158	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.98e-05	0.000155	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MAPK1—kidney cancer	7.71e-05	0.00015	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GPC3—kidney cancer	7.67e-05	0.00015	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CA2—kidney cancer	7.46e-05	0.000145	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—kidney cancer	7.28e-05	0.000142	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ALAD—kidney cancer	7.27e-05	0.000142	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ST3GAL2—kidney cancer	7.1e-05	0.000138	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ALDH1A1—kidney cancer	6.94e-05	0.000135	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PGK1—kidney cancer	6.65e-05	0.00013	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC5A3—kidney cancer	6.65e-05	0.00013	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—LDHB—kidney cancer	6.52e-05	0.000127	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CA9—kidney cancer	5.66e-05	0.00011	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.53e-05	0.000108	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CRABP1—kidney cancer	4.81e-05	9.37e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ITPR2—kidney cancer	4.47e-05	8.71e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.12e-05	8.03e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ACHE—kidney cancer	4.08e-05	7.95e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTT1—kidney cancer	4.08e-05	7.95e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SCARB1—kidney cancer	3.86e-05	7.52e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTGS1—kidney cancer	3.82e-05	7.45e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PSMD7—kidney cancer	3.75e-05	7.3e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—BCHE—kidney cancer	3.55e-05	6.92e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.51e-05	6.84e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.39e-05	6.6e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.29e-05	6.41e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.87e-05	5.59e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTP1—kidney cancer	2.83e-05	5.51e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ABCB1—kidney cancer	2.68e-05	5.21e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTM1—kidney cancer	2.6e-05	5.06e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.46e-05	4.8e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.02e-05	3.94e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—POMC—kidney cancer	1.84e-05	3.58e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTGS2—kidney cancer	1.46e-05	2.85e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTEN—kidney cancer	1.28e-05	2.49e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CA—kidney cancer	9.01e-06	1.76e-05	CbGpPWpGaD
